Overview

I3LTE4: Intensive Insulin Therapy and Production of LTE4 in Patients With Diabetes

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the effect of a 3-month intensive insulin therapy on urinary leukotriene E4 (LTE4) excretion in patients with diabetes.
Phase:
N/A
Details
Lead Sponsor:
University Hospital, Grenoble
Treatments:
Insulin
Insulin, Globin Zinc